Salivary Hepcidin ELISA: Metabolites as Biomarkers for Disease

Sep 17, 2018 | News, Products | 0 comments

Salivary Hepcidin ELISA: Metabolites as Biomarkers for Disease

Published In:

Metabolomics Research – Special Feature of Select Science®

Analysis of metabolites found in saliva is a favorable diagnostic solution, as it can be obtained by methods sample collection methods which are both a non-invasive and stress-free. Tools such as the DRG Salivary Hepcidin ELISA can be used for the quantification of metabolites such as Hepcidin in a standardized, precise and efficient way.


Are you interested in more DRG products, that are listed at Select Science? 
Follow this link!

DRG International

DRG International

DRG International, Inc. is a leading specialty medical diagnostics and equipment manufacturer, and distributor with operations in more than 110 countries.
DRG International

News and Updates

DRG:HYBRiD-XL® Summer Workshop Recap

  On June 4th-6th, the DRG:HYBRiD-XL Summer workshop took place in Germany with distributors from Nepal, Lebanon, and Australia. It was a very enthusiastic group! Key topics discussed included real situations in the field and Hepcidin as a new biomarker. Attendees...

read more

Sign Up for Our Newsletter

  • By submitting this form, you are granting: DRG International, Inc., 841 Mountain Avenue, Springfield, NJ, 07081, permission to email you. You may unsubscribe via the link found at the bottom of every email. (See our Email Privacy Policy ( for details.) Emails are serviced by Constant Contact.

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.